Combined targeting of KRT23 and NCCRP1 as a potential novel therapeutic approach for the treatment of triple-negative breast cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jian,Zhou

第一单位： Department of Neurosurgery Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

作者： Jian,Zhou ^[1] ; Weiwei,Qian ^[2] ; Cuiliu,Huang ^[3] ; Cunjun,Mai ^[3] ; Yimei,Lai ^[3] ; Zhiqin,Lin ^[3] ; Guie,Lai ^[3]

作者单位： Department of Neurosurgery Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China. ^[1] Emergency Department, Shangjinnanfu Hospital, West China Hospital, Sichuan University, Chengdu, China. ^[2] Department of Vascular and Breast Surgery, First Affiliated Hospital of Gannan Medical University, Ganzhou, China. ^[3]

关键词 Keratin23 (KRT23)Triple-negative breast cancers non-specific cytotoxic cell receptor 1 (NCCRP1)tumor immune microenvironment

DOI 10.21037/gs-22-486

PMID 36353580

发布时间 2022-11-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Gland surgery

2022年11卷10期

1673-1682页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Combined targeting of KRT23 and NCCRP1 as a potential novel therapeutic approach for the treatment of triple-negative breast cancer.

Gland surgery

相似文献

Gland surgery

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Combined targeting of KRT23 and NCCRP1 as a potential novel therapeutic approach for the treatment of triple-negative breast cancer.

Gland surgery

相似文献

Gland surgery

相关期刊

检索历史清除